Role of LH in ovarian stimulation: considerations (Q36494660)

14 August 2017

1 reference

title

Role of LH in ovarian stimulation: considerations (English)

1 reference

14 August 2017

Georg Griesinger

1

1 reference

14 August 2017

Klaus Diedrich

series ordinal

2

1 reference

14 August 2017

publication date

1 April 2006

1 reference

14 August 2017

number of pages

3

1 reference

Reproductive BioMedicine Online

inferred from page(s)

published in

1 reference

14 August 2017

volume

12

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

404-406

1 reference

Increasing the dose of human menopausal gonadotrophins on day of GnRH antagonist administration: randomized controlled trial

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

Ovulation induction in the new millennium: recombinant follicle-stimulating hormone versus human menopausal gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

1 reference

7 January 2021

Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized cont

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

LH improves early follicular recruitment in women over 38 years old.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

Use of follicle-stimulating hormone alone (urofollitropin) to stimulate the ovaries for assisted conception after pituitary desensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

To add or not to add LH: consideration of LH concentration changes in individual patients

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

Use of recombinant LH in a group of unselected IVF patients

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961990-6

7 January 2021

10.1016/S1472-6483(10)61990-6

Identifiers

DOI

1 reference

14 August 2017

1 reference